Detail page

Knowledge Web

Person

Tim Sauer (1981-)

Arzt

Name	Tim Sauer
Time	1981- (Date of birth and death)
Place	Deutschland
Profession	Arzt (characteristic profession)
Related	Universitätsklinikum Heidelberg. Zentrum für Innere Medizin (seit 2019)
Record type	Person
GND-Identifier	138282013
Record ID	138282013
Involved in show all Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial Alterations of cohesin complex genes in acute myeloid leukemia : differential co-mutations, clinical presentation and impact on outcome Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstruction Modular tumor endoprostheses in surgical palliation of long-bone metastases: A reduction in tumor burden and a durable reconstruction Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Tim Sauer (1981-)

Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

Alterations of cohesin complex genes in acute myeloid leukemia : differential co-mutations, clinical presentation and impact on outcome

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia

Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstruction

Modular tumor endoprostheses in surgical palliation of long-bone metastases: A reduction in tumor burden and a durable reconstruction

Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes